Advik Laboratories Share Price

0.36

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 19-Jun-2020 - -
ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Tuesday, 30th June, 2020 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001 to inter-alia, consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2020 and to carry on any other business with the permission of the Board. Audited Results(Cancelled) (As per BSE Bulletin Dated 25/06/2020)
Board Meeting - 30-Jan-2020 - -
ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Thursday, 13th February, 2020 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001 to inter-alia, consider and approve the Unaudited Financial Results of the Company for the quarter ended 31st December, 2019 and any other business with the permission of the Board. Outcome of the Board Meeting and Submission of Unaudited Financial Results for the quarter and nine months ended 31st December, 2019 as required under Regulation 33 of the SEBI (LODR) Regulations, 2015. Pursuance to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Thursday, 13 February, 2020 concluded just now has, inter-alia, transacted the following businesses: 1. Considered and Approved the Unaudited Financial Results of the Company for the quarter ended 31st December, 2019. 2. Considered and taken on records Limited Review Report for the Unaudited Financial Results for the quarter and nine months ended 31st December, 2019, 3. The Board also considered and took note of the request letter sent to Indian Overseas Bank (1OB) wherein the company has requested IOB to allow it some time to settle its outstanding debts of IOB, as per the terms of One Time Settlement (OTS) entered into by the company with the IOB, which the company was supposed to settle by 30th September, 2019. The request letter of the company is still under consideration at the end of IOB. (As Per BSE Announcement dated on 13/02/2020)
Board Meeting - 02-Nov-2019 - -
ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Wednesday, 13th November, 2019 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001 to inter-alia, consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2019 and any other business with the permission of the Board. Outcome of the Board Meeting and Submission of Unaudited Financial Results for the quarter and half year ended 30th September, 2019 as required u/r 33 of the SEBI (LODR) Regulations, 2015. Submission of Unaudited Financial Results for the quarter and half year ended 30th September 2019 as required u/r 33 of the SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated 13.11.2019)
Board Meeting - 16-Aug-2019 - -
ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 30 read with Schedule III of the SEBI LODR) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the company is scheduled to be held on Friday, 23d August, 2019 at the corporate office of the company at 703, Arunachal Building, 19,Barakhambha Road, Connaught Place, New Delhi-110001, interalia, to consider the sale of Manufacturing Unit of the company situated at 138, Roz- Ka- Meo Industrial Area, Sohna, Gurgaon Haryana- L221.03 (i.e. the Land and Building and Plant and Machinery of the Company on as is whereis basisJ and to do any other business with the permission of the Board. Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the company in its meeting held today, i.e., on Friday, 23rd August, 2019 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001, and concluded just now, has, inter-alia, considered the business as is mentioned in the attached file. Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the company in its meeting held today, i.e., on Friday, 23rd August, 2019 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001, and concluded just now, has, inter-alia, considered the business as is mentioned in the attached file. Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the company in its meeting held today, i.e., on Friday, 23rd August, 2019 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001, and concluded just now, has, inter-alia, considered the business as is mentioned in the attached file. (As Per BSE Announcement Dated 23.08.2019)
Board Meeting - 01-Aug-2019 - -
ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015,notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Monday, 12th August, 2019 at the corporate office of the company at 703,Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001 to inter-alia, consider and to approve The Unaudited Financial Results of the Company for the quarter ended June 30, 2019, and any other business with the permission of the Board. Submission of Newspaper Publication w.r.t Notice of Board Meeting for considering the Unaudited Financial Results for the quarter ended 30th June, 2019 (As Per BSE Announcement Dated 03.08.2019) Outcome of the Board Meeting and Submission of Unaudited Financial Results for the quarter ended 30th June, 2019 as required u/r 33 of the SEBI (LODR) Regulations, 2015 This is to inform you that in pursuance to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Monday 12th August, 2019 at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded just now has, inter-alia, transacted the following businesses: 1. Considered and Approved the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June, 2019. 2. Considered and taken on records Limited Review Report submitted by the Statutory Auditors of the company on the Unaudited Financial Results of the Company for the quarter ended 30th June, 2019. 3. The Board also considered and took note of the OTS Sanction letter received from Indian Overseas Bank wherein the said Bank has approved the One Time Settlement offer for Rs. 8.30 Crore made by the Company to settle the loan obtained by the Company from the said Bank. (As Per BSE Announcement dated on 12/08/2019)